Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px

News > All

Total search results: 3657 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 23 24 25 ... 35 36 37  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Immune Regulation Ltd.. (9/21/20). "Press Release: Immune Regulation Limited Raises £40.6 Million / $53.4 Million Series B Equity Financing". London & Boston, MA. 2020-09-21
T-Knife GmbH. (9/21/20). "Press Release: T-Knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy". Berlin & Somerset, NJ. 2020-09-21
Inflazome Ltd.. (9/21/20). "Press Release: Inflazome Announces Acquisition by Roche". Dublin & Cambridge. 2020-09-21
NovaGo Therapeutics AG. (9/21/20). "Press Release: NovaGo Therapeutics Appoints Ian Metcalfe as CEO". Schlieren. 2020-09-21
Glycotope GmbH. (9/21/20). "Press Release: DCprime and Glycotope Sign Licensing Agreement to Advance Program Combining Cancer Vaccination and Therapeutic Antibody Platforms". Leiden & Berlin. 2020-09-21
Theolytics Ltd.. (9/21/20). "Press Release: Theolytics Announces Appointment of Immatics' Carsten Reinhardt to its Board of Directors". Oxford. 2020-09-21
GeneWerk GmbH. (9/21/20). "Press Release: GeneWerk Announces Growth Equity Investment from Ampersand Capital Partners". 2020-09-21
Singleron Biotechnologies. (9/20/20). "Press Release: Singleron Completes $30 Million Series A Financing". 2020-09-20
Novo Holdings A/S. (9/17/20). "Press Release: Novo Ventures Co-leads US$83m Series C Financing in Lava Therapeutics". Copenhagen. 2020-09-17
BioNTech SE. (9/17/20). "Press Release: BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021". Mainz. 2020-09-17
Boehringer Ingelheim. (9/17/20). "Press Release: Boehringer Ingelheim and Mirati Therapeutics Annonce Clinical Collaboration to Study BI 1701963, a SOS1::pan-KRAS Inhibitor in Combination with MRTX849, a KRAS G12C Selective Inhibitor". Ingelheim & San Di 2020-09-17
InflaRx N.V.. (9/17/20). "Press Release: InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer". Jena. 2020-09-17
Qiagen N.V.. (9/17/20). "Press Release: Qiagen Fully Acquires NeuMoDx Molecular, Inc., Rounding Out Portfolio of PCR-based Diagnostic Automation Systems". Hilden & Ann Arbor, MI. 2020-09-17
Infarm – Indoor Urban Farming GmbH. (9/17/20). "Press Release: Infarm Raises $170M during Pandemic to Grow Largest Urban Vertical Farming Network in the World". Berlin. 2020-09-17
Lava Therapeutics B.V.. (9/17/20). "Press Release: Lava Therapeutics Announces $83 Million Series C Financing to Advance Novel Immuno-Oncology Programs". Utrecht & Philadelphia, PA. 2020-09-17
Moderna, Inc.. (9/16/20). "Press Release: Moderna Announces First Commercial Organization Outside North America in Switzerland". Cambridge, MA. 2020-09-16
Dinaqor AG. (9/16/20). "Press Release: Dinaqor AG Appoints Eduard Ayuso as Chief Technology Officer". Pfäffikon. 2020-09-16
Polyneuron Pharmaceuticals AG. (9/16/20). "Press Release: Polyneuron Extends Series A to CHF 36.5 Million with Additional CHF 14 Million". Basel. 2020-09-16
Regulatory and Quality Solutions LLC. (9/16/20). "Press Release: Regulatory and Quality Solutions LLC (R&Q) Acquires Maetrics to Form the Largest Medical Device-Focused Global Regulatory and Quality Consultancy". Monroeville, PA. 2020-09-16
BioNTech SE. (9/15/20). "Press Release: BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162". Mainz. 2020-09-15
Amadeus Capital Partners. (9/15/20). "Press Release: Amadeus Appoints New Partners Edward Kliphuis and Kai Schmitz". London & Bogotá. 2020-09-15
Immatics N.V.. (9/15/20). "Press Release: Immatics Appoints Biotech Executive Eliot Forster to Board of Directors". Tübingen & Houston, TX. 2020-09-15
ImCheck Therapeutics SAS. (9/15/20). "Press Release: ImCheck Announces Investment by BB Pureos Bioventures to Close Series B Fundraising with Total of €54 million ($64 million)". Marseille. 2020-09-15
Proteome Sciences plc. (9/14/20). "Press Release: Appointment of Chief Executive Officer". 2020-09-14
Evotec SE. (9/14/20). "Press Release: Evotec and BIOASTER Partner to Build a Technology and Innovation Hub in Lyon". Hamburg. 2020-09-14
ERS Genomics Ltd.. (9/14/20). "Press Release: ERS Genomics Provides Comment on US Patent Office Motions Decisions in CRISPR/Cas9 Interference Case". Dublin. 2020-09-14
4SC AG. (9/11/20). "Press Release: 4SC and Maruho Discontinue Collaboration for Development of 4SC’s Kv1.3 Inhibitors". Planegg-Martinsried. 2020-09-11
Bruker Corporation. (9/11/20). "Press Release: Bruker Announces Acquisition of Canopy Biosciences, LLC". Billerica, MA. 2020-09-11
Boehringer Ingelheim. (9/11/20). "Press Release: Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia". Ingelheim & New 2020-09-11
Bayer AG. (9/10/20). "Press Release: Bayer – Supervisory Board Extends CEO Werner Baumann’s Contract until the End of April 2024. Company also Announces Progress in Roundup Settlements". Leverkusen. 2020-09-10
Gain Therapeutics, Inc.. (9/10/20). "Press Release: Gain Therapeutics Announces Research Collaboration with Sumitomo Dainippon Pharma Co., Ltd to Advance Gain’s Lysosomal Enzyme Allosteric Regulator Program". Bethesda, MD. 2020-09-10
Recursion Pharmaceuticals, Inc.. (9/9/20). "Press Release: Recursion Secures $239 Million in Equity Financing to Advance Technology-Enabled Drug Discovery Platform and Pipeline". Salt Lake City, UT. 2020-09-09
Bayer AG. (9/9/20). "Press Release: Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases". Berlin & Salt Lake City, UT. 2020-09-09
Bayer Pharmaceuticals Corporation. (9/9/20). "Press Release: Bayer Completes Acquisition of the UK-based Biotech Company Kandy Therapeutics Ltd.". Whippany, NJ. 2020-09-09
Evonetix Ltd.. (9/9/20). "Press Release: Evonetix and Analog Devices Collaborate onThird-Generation DNA Synthesis Platform". Cambridge. 2020-09-09
Merck KGaA. (9/9/20). "Press Release: Merck Announces € 59 Million Antibody-Drug Conjugate Manufacturing Expansion". Darmstadt. 2020-09-09
Valneva S.E.. (9/9/20). "Press Release: Valneva Announces New Ixiaro Supply Contract with the US Government Worth up to $166 Million". Saint-Herblain. 2020-09-09
Valneva S.E.. (9/8/20). "Press Release: Valneva Initiates Phase 3 Clinical Study for its Chikungunya Vaccine Candidate VLA1553". Saint-Herblain. 2020-09-08
Bruker Corporation. (9/8/20). "Press Release: Bruker Appoints Bonnie H. Anderson to its Board of Directors". Billerica, MA. 2020-09-08
Lonza Group Ltd.. (9/8/20). "Press Release: Sheba Medical Center Treats First Patient with CAR-T Cell Immunotherapy Manufactured Using the Lonza Cell Immunotherapy Manufactured Using the Lonza Cocoon Platform". Basel & Tel Aviv. 2020-09-08
Vibalogics GmbH. (9/8/20). "Press Release: Vibalogics Appoints Global CEO to Lead U.S. Expansion". 2020-09-08
NBE Therapeutics AG. (9/8/20). "Press Release: Exelixis and NBE-Therapeutics Enter into Exclusive Collaboration and License Option Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer". Alameda, CA & Basel. 2020-09-08
IcanoMab GmbH. (9/7/20). "Press Release: IcanoMab GmbH Founded with Private Funding to Develop Precision Canonical Monoclonal Antibodies in Oncology, Immune-Modulation, Acute Inflammation and Most Urgently for Covid-19". Polling. 2020-09-07
CMS. (9/7/20). "Pressemitteilung: CMS begleitet Gründer des KI Start-ups Semalytix bei Serie-A Finanzierungsrunde". Berlin. 2020-09-07
Debiopharm International SA. (9/7/20). "Press Release: Belgian Scale-up Oncomfort Raises €10 million in Series A Funding Co-led by Debiopharm and Crédit Mutuel Innovation". Brussels, Lausanne & Paris. 2020-09-07
Boehringer Ingelheim. (9/7/20). "Press Release: Boehringer Ingelheim Discontinues Development of BI 1467335 for Diabetic Retinopathy". Ingelheim & Sydney. 2020-09-07
EuropaBio. (9/3/20). "Press Release: Novartis’s Andrew Topen Appointed as New Chairman of EuropaBio". 2020-09-03
Evotec SE. (9/2/20). "Press Release: Evotec Expands Its Proprietary Patient Database into Liver Disease with Unique Access to QUOD Biobank". Hamburg. 2020-09-02
BiomX Inc.. (9/2/20). "Press Release: BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for Inflammatory Bowel Disease". Ness Ziona. 2020-09-02
Merck KGaA. (9/2/20). "Press Release: Merck Places Hybrid Bond Amounting to €1.0 billion". Darmstadt. 2020-09-02
BioVersys AG. (9/1/20). "Press Release: BioVersys Announces CHF 19 Million Financing to Advance Novel AMR Candidates into Clinical Development". Basel. 2020-09-01
Oculis S.A.. (9/1/20). "Press Release: Oculis Establishes Presence in U.S. and Appoints Sylvia Cheung as Chief Financial Officer". Lausanne. 2020-09-01
Priavoid GmbH. (9/1/20). "Press Release: Philipp Bürling Appointed CEO of Priavoid". 2020-09-01
Aimmune Therapeutics, Inc.. (8/31/20). "Press Release: Aimmune Therapeutics Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science". Brisbane, CA. 2020-08-31
Semalytix GmbH. (8/31/20). "Press Release: Semalytix Closes Series A Investment Totaling €4.3m". 2020-08-31
High-Tech Gründerfonds Management GmbH. (8/28/20). "Press Release: Aignostics Raises €5m Seed Round to Advance AI-powered Pathology". 2020-08-28
Cellink AB. (8/28/20). "Press Release: Cellink Welcomes New Scientific Advisor Professor Ido Amit from the Weizmann Institute of Science". Gothenburg. 2020-08-28
Bayer AG. (8/27/20). "Press Release: Bayer and Northpond Ventures Lead USD 55 Million Series A Financing Round for Triumvira Immunologics". Leverkusen & Austin, TX. 2020-08-27
Addex Therapeutics S.A.. (8/27/20). "Press Release: Addex and the SIB Swiss Institute of Bioinformatics Receive Innosuisse Grant to Repurpose Potent Dopamine Antagonist Using Computational Modelling". Geneva. 2020-08-27
Bayer AG. (8/27/20). "Press Release: Bayer Receives Approval for Xofigo in China [Not intended for U.S. and UK Media]". Berlin. 2020-08-27
Cellink AB. (8/27/20). "Press Release: Cytena and AstraZeneca Collaborate to Develop Plate Based Microbioreactors for Cell Line Development Workflows". 2020-08-27
Biognosys AG. (8/27/20). "Press Release: Biognosys Announces Nature Communications Publication in Collaboration with ETH Zurich, Bayer, and BASF". Schlieren. 2020-08-27
Foundation Medicine, Inc.. (8/26/20). "Press Release: FDA Approves Foundation Medicine's FoundationOne Liquid CDx, a Comprehensive Pan-Tumor Liquid Biopsy Test with Multiple Companion Diagnostic Indications for Patients with Advanced Cancer". Cambridge, 2020-08-26
Autifony Therapeutics Ltd.. (8/26/20). "Press Release: Autifony Therapeutics Regains Rights to Clinical Stage Kv3 Programme". Stevenage. 2020-08-26
Freenome, Inc.. (8/26/20). "Press Release: Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection". South San Francisco, CA. 2020-08-26
Cytosurge AG. (8/26/20). "Press Release: Cytosurge Announces Appointment of Thomas Bachmann to Board of Directors". Zurich. 2020-08-26
Eppendorf AG. (8/25/20). "Press Release: Eppendorf AG Records Strong First Half-year 2020. Consolidated Revenue Grows by 6.6% to €403.7 Million in the First Six Months > Consolidated revenue grows by 6.6% to €403.7 million in the first six months". Hamb 2020-08-25
Bayer AG. (8/24/20). "Press Release: Bayer and Informed Data Systems Inc. (One Drop) Join Forces to Jointly Develop Digital Health Products across Therapeutic Areas". Berlin. 2020-08-24
Bruker Corporation. (8/24/20). "Press Release: Bruker and Purity-IQ Sign Partnership Agreement to Transform the Cannabis Regulatory Landscape". Billerica, MA. 2020-08-24
Moderna, Inc.. (8/24/20). "Press Release: Moderna Confirms Advanced Discussions with European Commission to Supply Europe with 80 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)". Cambridge, MA. 2020-08-24
Qiagen N.V.. (8/21/20). "Press Release: Qiagen Announces New Chairman of Supervisory Board". Venlo. 2020-08-21
Singleron Biotechnologies. (8/21/20). "Press Release: Berry Genomics and Singleron Biotechnologies Moved into Strategic Slliance". 2020-08-21
Scienion AG. (8/19/20). "Press Release: Cellink Has Entered into an Agreement to Acquire Precision Dispensing Company Scienion AG". 2020-08-19
Kronos Bio, Inc.. (8/19/20). "Press Release: Kronos Bio Appoints Dr. Yasir Al-Wakeel as Chief Financial Officer and Head of Corporate Development". San Mateo, CA & Cambridge, MA. 2020-08-19
CureVac B.V.. (8/18/20). "Press Release: CureVac Announces Closing of Initial Public Offering". Tübingen & Boston, MA. 2020-08-18
Evotec SE. (8/18/20). "Press Release: Evotec and Novo Nordisk Form Strategic Alliance to Develop Novel Therapies for Kidney Diseases". Hamburg. 2020-08-18
Qiagen N.V.. (8/18/20). "Press Release: Qiagen Expands Integrated Coronavirus NGS and Software Solutions to Accelerate COVID-19 Research". Hilden & Germantown, MD. 2020-08-18
Bayer AG. (8/18/20). "Press Release: Bayer Names Sara Boettiger as Head of Global Public Affairs, Science and Sustainability for Crop Science Division". Monheim. 2020-08-18
Exscientia Ltd.. (8/18/20). "Press Release: Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats". Brussels. 2020-08-18
Hua Medicine (Shanghai) Ltd.. (8/17/20). "Press Release: Bayer and Hua Medicine Announce Commercialization Agreement and Strategic Partnership for Investigational First-in-Class Novel Diabetes Treatment Dorzagliatin in China". Beijing & Shanghai. 2020-08-17
Merck KGaA. (8/17/20). "Press Release: Merck Appoints Liz Henderson as New Regional Vice President, Merck Biopharma APAC". Singapore. 2020-08-17
Seres Therapeutics, Inc.. (8/17/20). "Press Release: Seres Therapeutics, Inc. Announces Closing of Public Offerings of 12,075,000 Shares of Common Stock". Cambridge, MA. 2020-08-17
CureVac B.V.. (8/14/20). "Press Release: CureVac Announces Pricing of Initial Public Offering". Tübingen & Boston, MA. 2020-08-14
Qiagen N.V.. (8/13/20). "Press Release: Qiagen to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation after Voluntary Public Takeover Offer Falls Short". Venlo. 2020-08-13
Novo Holdings A/S. (8/12/20). "Press Release: Novo Ventures Portfolio Company F2G Closes US$60.8 Million Financing". Copenhagen. 2020-08-12
Atriva Therapeutics GmbH. (8/11/20). "Press Release: Atriva Announces Closing of € 8.6 Million ($ 10.2 Million) Oversubscribed Convertible Loan". Tübingen. 2020-08-11
Bayer AG. (8/11/20). "Press Release: Bayer to Acquire UK-based Biotech Kandy Therapeutics Ltd. [Not intended for U.S. and UK Media]". Berlin. 2020-08-11
CureVac B.V.. (8/10/20). "Press Release: CureVac Announces Proposed Initial Public Offering of Common Shares". Tübingen. 2020-08-10
Inveox GmbH. (8/10/20). "Press Release: Roche Diagnostics Germany and Inveox Jointly Drive Digital Solutions in Histopathology". Mannheim & Garching. 2020-08-10
NBE Therapeutics AG. (8/10/20). "Press Release: NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors". Basel. 2020-08-10
Immunic, Inc.. (8/10/20). "Press Release: Immunic, Inc. Announces Closing of $103.5 Million Public Offering, including Full Exercise of Underwriters’ Option to Purchase Additional Shares". New York, NY. 2020-08-10
Bruker Corporation. (8/7/20). "Press Release: Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass Spectrometry". Billerica, MA. 2020-08-07
T-Knife GmbH. (8/6/20). "Press Release: T-Knife Completes € 66 Million Series A Financing to Develop Next-Generation T-Cell Therapies". Berlin. 2020-08-06
Merck KGaA. (8/6/20). "Press Release: Leadership Change within Group Communications at Merck". Darmstadt. 2020-08-06
Evotec SE. (8/5/20). "Press Release: Evotec and Secarna Pharmaceuticals Form Strategic Partnership in the Field of Antisense Therapy". Hamburg & Marburg. 2020-08-05
Immunic, Inc.. (8/5/20). "Press Release: Immunic, Inc. Announces Pricing of $90.0 Million Public Offering of Common Stock". New York, NY. 2020-08-05
Affimed N.V.. (8/5/20). "Press Release: Affimed Announces Two New Appointments to Its Supervisory Board". Heidelberg. 2020-08-05
AC Immune S.A.. (8/5/20). "Press Release: AC Immune Reports Q2 2020 Financial Results and Provides Business Update". Lausanne. 2020-08-05
Versant Ventures. (8/5/20). "Press Release: Versant Ventures Launches Matterhorn Biosciences". Basel. 2020-08-05
GentiBio, Inc.. (8/5/20). "Press Release: GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Infl 2020-08-05
next pagenext page 1 2 3 ... 23 24 25 ... 35 36 37  next pagenext page



Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px

» top